Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cgh.2014.07.049PMID 25102445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of adenocarcinoma among patients with Barrett's esophagus.

  2011cited by this paper
• American Gastroenterological Association technical review on the management of Barrett's esophagus.

  2011cited by this paper
• Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.

  2011cited by this paper
• American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

  2011cited by this paper
• Randomized comparison of 3 different-sized biopsy forceps for quality of sampling in Barrett's esophagus.

  2010cited by this paper
• Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study

  2010cited by this paper
• Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated

  2010cited by this paper
• Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus.

  2009cited by this paper
• Radiofrequency ablation in Barrett's esophagus with dysplasia.

  2009cited by this paper
• The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.

  2008cited by this paper
• Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis.

  2008cited by this paper
• Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994–2006

  2008cited by this paper
• Normalization of Intestinal Metaplasia in the Esophagus and Esophagogastric Junction: Incidence and Clinical Data

  2007cited by this paper
• Anatomical Patterning of Visceral Adipose Tissue: Race, Sex, and Age Variation

  2007cited by this paper
• Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

  2007cited by this paper
• Low-grade dysplasia in Barrett's esophagus has a high risk of progression

  2007cited by this paper
• Frequency of Barrett’s neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study

  2006cited by this paper
• Barrett's Esophagus at a Tertiary Care Center: Association of Age on Incidence and Prevalence of Dysplasia and Adenocarcinoma

  2006cited by this paper
• Efficacy of Nissen Fundoplication Versus Medical Therapy in the Regression of Low-Grade Dysplasia in Patients With Barrett Esophagus: A Prospective Study

  2006cited by this paper
• Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

  2006cited by this paper
• Comparison of visceral adipose tissue mass in adult African Americans and whites.

  2005cited by this paper
• Barrett Esophagus: Risk Factors for Progression to Dysplasia and Adenocarcinoma

  2005cited by this paper
• Dysplasia and Risk of Further Neoplastic Progression in a Regional Veterans Administration Barrett's Cohort

  2005cited by this paper
• The Prevalence of Barrett's Esophagus and Erosive Esophagitis in Patients Undergoing Upper Endoscopy for Dyspepsia in a VA Population

  2004cited by this paper
• Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study

  2003cited by this paper
• Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.

  2003cited by this paper
• Clinical and Pathologic Response of Barrett's Esophagus to Laparoscopic Antireflux Surgery

  2003cited by this paper
• p53 expression in low grade dysplasia in Barrett’s esophagus: correlation with interobserver agreement and disease progression

  2002cited by this paper
• p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression

  2002cited by this paper
• Risk Stratification of Barrett's Esophagus: Updated Prospective Multivariate Analysis

  2001cited by this paper
• Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

  2001cited by this paper
• p53 protein overexpression in low grade dysplasia (LGD) in barrett's esophagus: Immunohistochemical marker predictive of progression

  2001cited by this paper
• Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia.

  2001cited by this paper
• Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

  2000cited by this paper
• The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

  2000cited by this paper
• Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus.

  1997cited by this paper
• Visceral adipose tissue differences in black and white women.

  1995cited by this paper
• Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.

  1992cited by this paper
• Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort

  1992cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper

• AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.

  2024cites this paper
• Diagnosis and Management of Barrett’s Esophagus

  2023influential citation
• External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of United States veterans.

  2022cites this paper
• Prediction of Neoplastic Progression in Barrett's Esophagus Using Nanoscale Nuclear Architecture Mapping: A Pilot Study.

  2022cites this paper
• Today’s Mistakes and Tomorrow’s Wisdom… In Barrett’s Surveillance

  2022cites this paper
• The Utility of Biomarkers for Risk Stratification in Barrett’s Esophagus

  2021cites this paper
• Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression

  2021cites this paper
• Radiofrequency Ablation

  2021cites this paper
• Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia.

  2020cites this paper
• Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus

  2020cites this paper
• Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett’s esophagus

  2020cites this paper
• Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis

  2020cites this paper
• The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract

  2019cites this paper
• Ablation for Patients With Barrett or Dysplasia

  2019cites this paper
• Endobrachyœsophage

  2019cites this paper
• Barrett’s Esophagus: Diagnosis and Management

  2019cites this paper
• Barrett’s Esophagus with Epithelial Changes Indefinite for Dysplasia: What we Have Learnt from Recent Studies

  2018cites this paper
• Management of low-grade dysplasia in Barrett’s esophagus: Ablate or survey?

  2018cites this paper
• Management of Barrett's esophagus with low-grade dysplasia.

  2018cites this paper
• A case of esophageal actinomycosis with a unique morphology presenting as a refractory ulcer

  2018cites this paper
• Yield of Higher‐Grade Neoplasia in Barrett’s Esophagus With Low‐Grade Dysplasia Is Double in the First Year Following Diagnosis

  2018cites this paper
• Surveillance in Barrett’s Esophagus and Dysplasia

  2017cites this paper
• Disease Progression in Barrett’s Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis

  2017cites this paper
• Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.

  2017cites this paper
• The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus-associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society.

  2017cites this paper
• Best of foregut: esophagus, stomach, and duodenum.

  2017cites this paper
• Predictors of Progression in Barrett’s Esophagus with Low-Grade Dysplasia: Results from a Multicenter Prospective BE Registry

  2017cites this paper
• Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.

  2017cites this paper
• THE USE OF SPECIAL STAINS IN THE DIAGNOSIS OF BARRETT ESOPHAGUS AND BARRETT DYSPLASIA : RECOMMENDATIONS FROM THE RODGER C . HAGGITT GASTROINTESTINAL PATHOLOGY SOCIETY

  2016cites this paper
• Screening and Surveillance of Barrett’s Esophagus

  2016cites this paper
• A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus

  2016cites this paper
• Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.

  2016cites this paper
• Systematic Review of Studies Reporting on Progression Rates to High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett ’ s Esophagus Patients With Low-Grade Dysplasia

  2016cites this paper
• Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer.

  2016cites this paper
• Barrett’s esophagus: lessons from recent clinical trials

  2016cites this paper
• Stratifying Risk in Barrett's Esophagus With Low-grade Dysplasia: Making the Best of a (Not So) Bad Situation.

  2016cites this paper
• Clinical significance and management of Barrett's esophagus with epithelial changes indefinite for dysplasia.

  2016cites this paper
• Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus

  2016cites this paper
• Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening

  2015cites this paper
• Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.

  2015cites this paper
• TissueCypher™: A systems biology approach to anatomic pathology

  2015cites this paper
• Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.

  2015cites this paper
• BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia

  2015cites this paper